Tevogen Bio Holdings Inc. (TVGN) Financials

TVGN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 4.7 million 13.6 million
March 31, 2026 4.9 million 14.8 million
Dec. 31, 2025 4.4 million 12.6 million
Sept. 30, 2025 4.5 million 12.3 million

TVGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.0 million 3.3 million
March 31, 2026 -2.7 million 2.8 million
Dec. 31, 2025 -2.2 million 2.4 million
Sept. 30, 2025 -3.6 million 3.2 million

TVGN Net Income

No data available :(

TVGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 1.1 million - -
March 31, 2026 692305 - 1.4 million
Dec. 31, 2025 552372 - 1.5 million
Sept. 30, 2025 1.0 million - 1.5 million

TVGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 3.8 million
March 31, 2026 3.5 million
Dec. 31, 2025 3.3 million
Sept. 30, 2025 3.9 million

TVGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 3 3.3 million 2.4 million -
March 31, 2026 1 3.1 million 2.3 million -
Dec. 31, 2025 64433 2.1 million 2.5 million -
Sept. 30, 2025 4 3.1 million 2.6 million -

TVGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 60144
March 31, 2026 - 59051
Dec. 31, 2025 - 85786
Sept. 30, 2025 - 27225

TVGN

Price: $6.65

52 week price:
3.64
70.00

Earnings Per Share: -6.29 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 26.6 million

Links: